The Impact of Syringe Safety during the COVID-19 Pandemic
Includes a Live Event on 12/01/2021 at 1:00 PM (EST)
Unsafe syringe practices when administering intravenous (IV) medications can cause patient harm and impact clinician practice. The need to prepare and manipulate IV medications at the patient’s bedside can increase the chance for patient infections, disrupt nursing workflow and efficiency, and increase the chance for medication errors. Complexities involved with the care of patients isolated with COVID-19 add to the risks and impact of unsafe syringe practices and amplifies system inefficiencies. Several professional organizations, including but not limited to the Institute for Safe Medication Practices (ISMP), INS, and the Joint Commission, recommend ready-to-administer (RTA) IV medications aimed to reduce the risks involved with unsafe syringe practices. This session will provide a review of unsafe syringe practices, the impact of practice changes resulting from COVID-19, and how to integrate ready-to-use IV medications into current practice.
Learning Objectives: At the conclusion of this webinar, learners will be able to:
· Describe unsafe syringe practices, including but not limited to improper use of cartridges, unnecessary dilution, mislabeling, and bedside compounding
· Explore changes in practice resulting from COVID-19 and how to minimize patient/clinician risk
· Verbalize the benefits of RTA IV medications and other methods to increase efficiency and how to integrate them into practice
Judith Jacobi, Pharm.D, FCCP, MCCM, BCCCP
Dr. Jacobi, a critical care clinical pharmacy specialist with 38 years of experience at the bedside, is now a senior consultant with Visante, a pharmacy consulting company. Through her role in the Voices of Vascular educational programming, she hopes to improve the safety of intravascular devices and medication administration. She has a broad publication record in critical care and has been active in many professional organizations.
CRNI® RUs: This session has been approved for 1 CRNI® recertification unit and meets the non INS Meeting criteria.
Contact Hours: This session has been approved for 1 contact hour
Expiration date for receipt of contact hours: December 1, 2024
To receive contact hours for this educational activity, you are required to attend the entire educational activity and complete the evaluation.
The Infusion Nurses Society is approved as a provider of continuing nursing education by the California Board of Registered Nursing, provider #CEP14209. The certificate must be retained by the attendee for a period of 4 years.